Bio-Rad Laboratories, Inc., a company specializing in life science research, clinical diagnostics, and analytical chemistry, has received a Buy recommendation from UBS.
The company's net sales are divided between clinical diagnostic tests and automated systems (55.8%) and reagents, equipment, and instruments for biological research (44.1%).
Bio-Rad operates 16 production sites worldwide, with five in the United States and others in Germany, France, China, Poland, the United Kingdom, Switzerland, and Singapore. The United States is the largest market for the company, accounting for 42% of net sales, followed by Europe (30.7%), Asia (21.1%), and other regions (6.2%).